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Condensation: Peripartum hysterectomy incidence in Ireland has been consistently low at one case 
in every 3000 deliveries and adherence to guidelines is generally high. 
Short version of the article title: Peripartum hysterectomy in Ireland. 
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Abstract 
Background: The incidence of peripartum hysterectomy (PH) shows fifty-fold variation worldwide 
(0.2–10.5/1000 deliveries) and risk factors include advancing maternal age and parity, previous 
caesarean section (CS) and abnormal placentation. 
Objectives: In this first national study of PH in Ireland, our objectives were threefold: to describe the 
national trend in PH incidence over 15 years since 1999; to assess risk of PH associated with 
morbidly adherent placenta (MAP), placenta praevia and postpartum haemorrhage (PPH) during 
2005-2013; and to describe the causes, interventions and outcomes of PH cases during 2011-2013. 
Study Design: For the 15-year time-trend analysis, PH cases and denominator data were extracted 
from Ireland’s Hospital In-Patient Enquiry database. Multivariate Poisson regression analysis 
assessed risk of PH associated with MAP, placenta praevia and PPH. In collaboration with the 20 Irish 
maternity units we carried out a three-year national clinical audit of severe maternity morbidity. PH 
was a notifiable morbidity and the audit included detailed review of MOH cases. 
Results: In 1999-2013 there were 298 PH cases, a rate of 0.32/1000 deliveries. During the period 
2005-2013, the PH rate was 50 times higher in deliveries involving PPH, 100 times higher with 
placenta praevia and 1000 times higher with MAP. During the clinical audit (2011-2013) there were 
65 PH cases, a rate of 0.33/1000 deliveries, increasing with advancing age and parity. The reporting 
of abnormal placentation, primarily the co-occurrence of placenta praevia and MAP, was linked with 
previous CS. Fifty-six of the 65 cases suffered MOH, most commonly associated with placenta 
praevia, MAP and uterine atony. Prophylactic and therapeutic uterotonic agents were appropriately 
used in the majority of cases. 
Conclusions: The incidence of PH in Ireland has been consistently low over 15 years, averaging one 
case every 3000 deliveries. The recognised risk factors of MAP, placenta praevia and PPH were 
independently associated with PH, with MAP being by far the strongest predictor. The vast majority 
of PH cases in our clinical audit were associated with MOH. Some deficiencies were noted in 
antenatal care, in certain elements of treatment and clinical governance protocols but adherence to 
guidelines was generally high. 
 
Key words: Peripartum hysterectomy; major obstetric haemorrhage; postpartum haemorrhage; 
caesarean section; morbidly adherent placenta; placenta accreta; placenta praevia. 
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Introduction 
Peripartum hysterectomy (PH), the concept of which was proposed in the 1700s, is a rare occurrence 
in modern obstetrics. In 1869, the ‘gravid uterus was for the first time amputated from a living 
woman’ by Horatio Storer.1 The first premeditated PH after which both the infant and mother 
survived was performed by Eduardo Porro, in 1876.2  
Nowadays PH is generally performed as a lifesaving measure in cases of major obstetric 
haemorrhage (MOH) when more conservative efforts fail. The most recent United Kingdom and 
Ireland Confidential Enquiry into Maternal Deaths reported 17 direct deaths due to obstetric 
haemorrhage, making it the third leading cause of direct maternal death (0.49/100,000 
maternities).3 Six of these women underwent PH. The report recommended ‘early recourse to 
hysterectomy……if simpler medical and surgical interventions prove ineffective’. Past triennial 
reports, along with national and international guidelines echo this principle, emphasising that 
recourse to hysterectomy should not be delayed ‘until the woman is in extremis…’. 4,5,6,7  
Rates of PH reported worldwide show fifty-fold variation (0.28 – 10.59/1000 deliveries). The UK 
Obstetric Surveillance System (UKOSS) study found its incidence to be 0.41/1000 births.10 This is in 
keeping with other nationwide studies - Denmark 0.24/100011, Holland 0.33/100012 and Canada 
0.35/100013 - but higher rates of 0.82/100014 and 0.85/100015 have been reported in the USA and 
Australia, respectively. Euro-Peristat reported rates of caesarean hysterectomy for postpartum 
haemorrhage (PPH) for 17 European countries in 2010 ranging from 0.0/1000 deliveries in Wales to 
1.3/1000 in Estonia.16 An international systematic review and the UKOSS study identified the 
following risk factors for PH: advancing maternal age and parity, previous caesarean section (CS) 
delivery and abnormal placentation.10,17 
In Ireland, high rates of PH in a single maternity unit prompted the establishment of an Inquiry in 
2003.18 This led to the first reported national PH rate of 0.28/1000 births for the period 1999-2003. 
While most Irish PH studies have been conducted in single institutions,19,20 a 40-year review of PH in 
the three Dublin maternity hospitals was recently performed.21 It reported a decrease in its 
incidence, from 0.9 to 0.2/1000 deliveries. The indication for PH also changed, with cases 
increasingly being attributed to morbidly adherent placenta (MAP), a finding in keeping with large 
international reviews. 12,14,15,22,23 
In this first national study of PH in Ireland, our objectives were threefold: to describe the national 
trend in incidence of PH over the 15 years since 1999; to assess the contribution to risk of PH made 
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by MAP, placenta praevia and PPH during 2005-2013; and, to describe the clinical characteristics, 
causes, interventions and outcomes relating to PH cases during 2011-2013. 
 
Materials and Methods 
Since 1999 all public maternity units in Ireland have contributed data to the Hospital In-Patient 
Enquiry (HIPE) database, thereby providing data on approximately 98% of all deliveries nationally. 
The HIPE system records diagnoses and procedures according to the International Statistical 
Classification of Diseases and Related Health Problems (ICD) using the Ninth Revision, Clinical 
Modification (ICD-9-CM) for hospital discharges in 1999-2004 and the Tenth Revision, Australian 
Modification (ICD-10-AM) for discharges in 2005-2013. 
We used delivery as the unit of analysis, defined as a hospital discharge following delivery of one or 
more liveborn or stillborn babies and indicated by the ICD-9-CM diagnosis code V27 or the ICD-10-
AM diagnosis code Z37. PH was defined as a delivery discharge with a recorded procedure code for 
hysterectomy (ICD-9-CM: 68.3-68.7 and 68.9; ICD-10-AM: 3565300, 3565301, 3565304, 3565700, 
3565800, 3566100, 3566400, 3566401, 3566700, 3566701, 3567000, 3567302, 3575000, 3575302, 
3575600, 3575603, 9044800, 9044801 and 9044802). 
For the 15-year time-trend analysis (1999-2013), the annual number of delivery discharges and PH 
cases associated with vaginal delivery and CS delivery were obtained via Health Atlas Ireland. The 
HIPE system’s use of ICD-10-AM since 2005 allowed data to be obtained separately for elective and 
emergency CS deliveries for 2005-2013. The annual PH incidence rate was calculated per 1000 
deliveries. Joinpoint regression analysis was used to assess the presence of linear trends in the PH 
rate and to find years when there was a change in such linear trends.24 
To assess the contribution made to risk of PH by MAP, placenta praevia and PPH, we focused on the 
period 2005-2013 when ICD-10-AM coding allowed the diagnosis of MAP to be recorded in the HIPE 
database. MAP may be recorded based on clinical diagnosis or histopathological examination but the 
basis for the diagnosis is not known from the HIPE data. We extracted the number of delivery 
discharges and cases of PH by maternal age and mode of delivery and with and without PPH, 
placenta praevia and MAP. We calculated the crude rate of PH by these variables with exact Poisson 
95% confidence intervals (CIs) and crude incidence rate ratios (IRRs) based on univariate Poisson 
regression. We then undertook a multivariate Poisson regression analysis to estimate the 
independent effect of the variables on risk of PH. Mode of delivery was not included in the 
multivariate analysis as there were too few cases of PH among vaginal deliveries and it was evident 
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that diagnosis of placenta praevia was almost deterministically linked with delivery by CS. As is 
common when examining the effect of multiple factors on the risk of rare events, there was 
overdispersion, i.e. the observed variation was greater than in a Poisson process, which rendered 
the Poisson regression inappropriate. To address this we undertook negative binomial regression 
which provided adjusted IRRs and their 95% CIs. 
In collaboration with the 20 Irish maternity units we carried out a clinical audit of severe maternity 
morbidity for the three-year period 2011-2013, having adapted the methods of the Scottish 
Confidential Audit.25 PH, defined as hysterectomy performed following delivery of a pregnancy or at 
any time during the puerperal period, was a reportable morbidity in the Irish audit and required the 
completion of a brief notification form which recorded indication for PH and core maternal and 
perinatal variables. For PH cases involving MOH (defined as blood loss of at least 2500ml, transfusion 
of five or more units of blood or documented treatment for coagulopathy25), a more detailed form 
was completed. 
Crude PH rates and IRRs were calculated as described above. Denominator data were extracted from 
the HIPE database for the overall PH rate and the PH rate by maternal age and for deliveries with 
and without MAP. Denominator data extracted from the 2011-2013 annual reports of the Irish 
National Perinatal Reporting System (NPRS) allowed the calculation of crude PH rates by nationality, 
parity and gestation at delivery. One unit did not contribute to our audit in 2011 and 2012 thereby 
reducing coverage to 95.2% of all Irish deliveries during the three years. For the calculation of PH 
rates, we excluded 2011-2012 deliveries in this unit from the HIPE denominator data and weighted 
the denominator data from the NPRS using the multiple 0.952. 
The HIPE data extracted for this study and the data collected by the clinical audit of severe maternity 
morbidity do not contain personal identifiers and were therefore exempt from institutional review 
board approval. 
 
Results 
In the 15-year period 1999-2013, there were 298 cases of PH among 927,495 deliveries, a rate of 
0.32/1000 deliveries (95% CI=0.29-0.36/1000). There was no notable variation or time trend in the 
national PH rate (Figure 1). The overall incidence among vaginal deliveries was low at 0.07/1000 
deliveries (95% CI=0.05-0.09/1000) and this rate decreased during the 15 years (annual rate change= 
-0.006/1000, 95% CI= -0.012 to -0.001/1000, p-value=0.044) so that the rate of PH fell from 
0.13/1000 vaginal deliveries in the triennium 1999-2001 (95% CI=0.08-0.21/1000) to 0.01/1000 in 
2011-2013 (95% CI=0.00-0.05/1000). The rate of PH among CS deliveries was far higher at 1.09/1000 
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(95% CI=0.96-1.24/1000), on average 16 times the incidence among vaginal deliveries (IRR=16.57, 
95% CI=12.10-22.69, p-value<0.001). The rate of PH among CS deliveries was volatile from year to 
year with no clear linear trends. There were four deaths among the 298 women who underwent a 
PH, suggesting a case fatality rate of 1.3% (95% CI=0.4-3.4%). 
During the nine-year period 2005-2013, there were 198 cases of PH among 609,599 deliveries, an 
incidence rate of 0.32/1000 deliveries (95% CI=0.28-0.37/1000), identical to the rate for the period 
1999-2013. There was tenfold variation in the crude rate of PH when examined by maternal age and 
a twentyfold difference by mode of delivery (Table 1). Respectively, PH was required following 17.5% 
of deliveries involving MAP, 2% involving placenta praevia and 0.5% involving PPH. Thus, the rate of 
PH was approximately 50 times higher in deliveries involving PPH, 100 times higher with placenta 
praevia and 1000 times higher with MAP. Considering these risk factors and maternal age together 
there was a five, ten and 90 times increased risk of PH associated with PPH, placenta praevia and 
MAP, respectively. 
There were 65 cases of PH reported from 196,514 deliveries in 2011-2013, a rate of 0.33/1000 
deliveries (95% CI=0.26-0.42/1000). This rate increased with advancing age and even more so with 
increasing parity (Table 2). As found for the period 2005-2013, almost half of PH cases in 2011-2013 
involved MAP. The rate of PH was approximately 17%, 1000 times higher in deliveries with MAP than 
in deliveries without MAP. Of the 31 cases of MAP-indicated PH, 61.3% were suspected antenatally. 
All but two PH cases involved CS delivery and three quarters had one or more previous CS deliveries. 
Antenatal ultrasound for placental location was performed for 90.9% (n=40/44) of the women with a 
history of CS. 
The reporting of abnormal placentation, primarily the co-occurrence of placenta praevia and MAP, 
as a causal factor for PH was linked with the woman’s previous history of CS (Table 3). Abnormal 
placentation was a reported cause of PH for 23.1% (3/13), 60.0% (9/15) and 89.7% (26/29) of 
women with no, one and two or more previous CS deliveries, respectively. 
Fifty-six of the 65 women who underwent a PH (86.2%) had a MOH. The nine non-MOH cases of PH 
involved delivery by elective CS. MAP was the indication in six non-MOH cases; cervical cancer, 
uterine anomaly and uterine rupture in a case of chorioangiocarcinoma were reported for the other 
three cases. 
Of the 56 MOH-related cases of PH, a single cause of haemorrhage was reported for 25 cases 
(44.6%) with multiple causes reported for the other 31 cases (55.4%). The most commonly reported 
were placenta praevia, MAP and uterine atony, as illustrated in the area-proportional Venn diagram 
in Figure 2.26 Uterine rupture was not reported in these cases of PH. 
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The majority of the 56 women who underwent a PH associated with MOH had received a 
prophylactic uterotonic agent (n=51, 91.1%; not received in two cases, 3.6%, not known in three 
cases, 5.4%). Similarly approximately 90% of the women were administered therapeutic uterotonic 
agents (n=50, 89.3%), the majority (n=42, 75.0%) received more than two agents. Six women 
received none (10.7%). 
The reported haemostatic surgical procedures undertaken for the 56 women who experienced MOH 
who ultimately required a PH is detailed in Table 4. For the nineteen women who received no 
surgical intervention prior to hysterectomy, the main indication for PH was abnormal placentation 
(n=14, 73.7%) with only one being for uterine atony. Four women in this subgroup received no 
uterotonic agents for treatment of MOH prior to PH - three cases of MAP and one case of cervical 
carcinoma who underwent a planned radical hysterectomy. 
The mean estimated blood loss in the 56 cases of PH involving MOH was 5558ml (range=1300-
13000ml). All of these women received a blood transfusion with, on average, ten units being 
transfused (range=1-24). Haemoglobin levels prior to the MOH event were reported for 54 of the 56 
women and indicated that one in three (n=18, 33.3%) were anaemic (Hb<10.5g/dl). Cell salvage was 
performed for three women (5.4%). Thirty-nine women (69.6%) were given blood products to 
correct coagulopathy. In at least 90% of cases, obstetric and anaesthetic consultants were reported 
to have been present at the time of MOH (n = 51, 91.1% and n=52, 92.9% respectively). For almost 
half of the MOH cases (n=27, 48.2%), it was reported that there was a case review or discussion in 
subsequent risk management meetings. 
Of the total of 65 women who underwent a PH whether associated with MOH or not, half (n=34, 
52.3%) were admitted to an intensive care unit (ICU) and five (7.7%) suffered a pulmonary 
embolism. Of the 60 babies delivered to the 65 women, half (n=29, 48.3%) were admitted to a 
neonatal ICU. Two babies, born prematurely, died in the neonatal period. 
 
Comment 
This first national study of PH in Ireland shows that the incidence is low and has been consistently 
low for 15 years, with approximately one case in every 3000 deliveries. This is similar to the rate in 
other European countries10,11,12 and in Canada13 but it is less than half the PH rate observed in the 
USA and Australia.14,15 The reasons behind this level of international variation warrants investigation. 
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The recognised risk factors of MAP, placenta praevia and PPH were independently associated with 
PH, with MAP being by far the strongest predictor. Consistent with this, the in-depth clinical review 
highlighted MAP and co-occurring placenta praevia as the most frequent causal factors for PH. These 
factors were particularly relevant for those women previously delivered by CS. In keeping with 
guidelines7, the vast majority of women with previous CS had antenatal ultrasound for placental 
location. Almost all women with MAP-indicated PH had previously been delivered by CS. An 
adherent placenta was suspected in 60% of these. While it is recognised that the definitive diagnosis 
of MAP can only be made at surgery, the observation that 40% of cases were not suspected 
highlights the need for improvements in antenatal detection. 
In keeping with previous publications, the vast majority of PH cases in our clinical study were 
associated with MOH. The MBRRACE-UK report recommends early recourse to hysterectomy in this 
setting.3 Even so, national and international guidelines recommend that treatment with uterotonic 
agents is still considered first line for management of both atony and placenta praevia/MAP.5,6 
Contrary to this, one in ten women in our study received no uterotonic therapy for management of 
MOH and not all of the women were administered a prophylactic uterotonic agent. Some women 
may decline prophylactic medications as part of a pre-discussed birth plan. This represents an 
opportunity not only to maintain education of medical and midwifery staff of the value of 
prophylaxis and treatment with uterotonics but also to educate women themselves. Furthermore, 
one in three MOH-related cases had no surgical intervention prior to PH. However, this may be 
explained by the fact that the majority of this subgroup had abnormal placentation as the indication 
for PH. 
PH is frequently performed in emergency situations on the background of substantial blood loss, 
contributing to significant perioperative morbidity for these women.27 It should be noted that, 
although recommended, cell salvage is not readily available in all Irish maternity units. One third of 
our study group who experienced MOH were anaemic (<10.5g/dl) prior to the event. As highlighted 
in the recent guidelines, low antenatal haemoglobin should be optimised prior to delivery.3,28 
Continued education of both staff and women of the importance of considering iron 
supplementation and consideration of repeated testing of haemoglobin in the third trimester is a 
priority for many in antenatal care. 
The high reported presence of consultants from both obstetric and anaesthetic specialities is to be 
commended. However, potential opportunities for training may have been missed as it was reported 
that only half of the cases were discussed in risk management meetings. 
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Several limitations of our study are acknowledged. The range of data in Ireland’s national inpatient 
database is limited. In particular, body mass index is not recorded and parity has only recently been 
included, although these were included in our clinical review. The clinical review was carried out in 
voluntary collaboration from the country’s maternity units which involved midwives and doctors 
collating data without protected time in a poorly-serviced information technology environment. 
Effects on data completeness and quality cannot be ruled out. However, data extracted from the 
HIPE databases corroborates our audit’s findings in terms of case-ascertainment. Furthermore, 
associations of similar magnitude were observed from analysis of both data sources. Evaluation of 
PH was limited due to the focus of our clinical audit on MOH. Several aspects of women’s care could 
therefore not be commented on such as future fertility desires, operative techniques and intra-
operative complications. 
In conclusion, PH is relatively rare in Ireland, affecting one woman in every 3000 deliveries. Despite 
this, the irreversible consequences remain for the affected woman and her family. Morbidly 
adherent placenta, in association with previous Caesarean delivery, was the strongest predictor of 
PH. The study confirms, in the Irish context, the established association between previous CS, MAP 
and PH29,30 and highlights the need for improvements in antenatal detection and management of 
abnormal placentation. It will be important to monitor whether such improvements help to maintain 
Ireland’s low PH rate or increase it as a result of more planned Caesarean hysterectomies. 
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Table 1. Incidence and risk of peripartum hysterectomy in Ireland in 2005-2013 by maternal age, mode of delivery, morbidly adherent placenta, placenta 
praevia and postpartum haemorrhage 
  PH cases Deliveries PH rate (95%CI) cIRR (95%CI) aIRR (95%CI) 
 All 198 609599 0.32 (0.28-0.37)   
Maternal age <30 years 22 231016 0.10 (0.06-0.14) 1.00 (ref.) 1.00 (ref.) 
 30-34 years 66 212107 0.31 (0.24-0.40) 3.27 1 (2.02-5.29) 1.32 (0.42-4.18) 
 35-39 years 82 138214 0.59 (0.47-0.74) 6.23 1 (3.89-9.97) 2.12 (0.68-6.65) 
 ≥40 years 28 28262 0.99 (0.66-1.43) 10.40 1 (5.95-18.18) 2.90 (0.87-9.60) 
Mode of 
delivery 
Vaginal 24 448623 0.05 (0.03-0.08) 1.00 (ref.)  
Caesarean section 174 160976 1.08 (0.93-1.25) 20.20 1 (13.19-30.96)  
MAP No 103 609058 0.17 (0.14-0.21) 1.00 (ref.) 1.00 (ref.) 
 Yes 95 541 175.6 (142.1-214.7) 1038.4 1 (785.7-1372.2) 89.2 1 (34.8-229.2) 
Placenta 
praevia 
No 131 606484 0.22 (0.18-0.26) 1.00 (ref.) 1.00 (ref.) 
Yes 67 3115 21.5 (16.7-27.3) 99.6 1 (74.2-133.7) 10.6 1 (4.5-25.1) 
PPH No 65 584556 0.11 (0.09-0.14) 1.00 (ref.) 1.00 (ref.) 
 Yes 133 25043 5.31 (4.45-6.29) 47.8 1 (35.5-64.3) 5.04 1 (2.12-12.00) 
PH, peripartum hysterectomy; PH rate per 1000 deliveries; CI, confidence interval; cIRR, crude incidence rate ratio; aIRR, adjusted incidence rate ratio from 
multivariable analysis including all other variables in the table except mode of delivery which was not included because there were too few cases of PH 
among vaginal deliveries and diagnosis of placenta praevia was almost deterministically linked with delivery by CS; MAP, morbidly adherent placenta; PPH, 
postpartum haemorrhage;  1 P < .001 
 
13 
 
Table 2: Characteristics and incidence of peripartum hysterectomy in Ireland in 2011-2013 
Characteristic Category n (%) PH rate (95%CI) cIRR (95%CI) 
All  65 (100.0) 0.33 (0.26-0.42)  
Age <30 years 8 (12.3) 0.12 (0.05-0.24) 1.00 ref.) 
 30-34 years 23 (35.3) 0.32 (0.20-0.48) 2.68 3 (1.20-5.98) 
 35-39 years 24 (37.0) 0.50 (0.32-0.74) 4.16 1 (1.87-9.27) 
 ≥40 years 10 (15.4) 0.96 (0.46-1.77) 8.00 1 (3.16-20.27) 
Irish Yes 40 (69) 0.26 (0.19-0.35) 1.00 (ref.) 
 No 18 (31) 0.38 (0.22-0.60) 1.45 (0.83-2.53) 
Parity 0 5 (7.7) 0.06 (0.02-0.15) 1.00 (ref.) 
 1 18 (27.7) 0.26 (0.15-0.41) 4.07 2 (1.51-10.97) 
 2 19 (29.2) 0.55 (0.33-0.86) 8.64 1 (3.22-23.13) 
 ≥3 23 (35.4) 1.26 (0.80-1.88) 19.80 1 (7.53-52.07) 
Previous CS No 13 (22.8)   
 Yes, one 15 (26.3)   
 Yes, two or more 29 (50.9)   
BMI (kg/m2) Lean (<25) 17 (34.7)   
 Overweight (25<30) 15 (30.6)   
 Obese (≥30) 17 (34.7)   
Pre-term No (≥37 weeks) 34 (53.1) 0.18 (0.12-0.25) 1.00 (ref.) 
 Yes (<37 weeks) 30 (46.9) 2.34 (1.58-3.34) 13.26 1 (8.12-21.66) 
Delivery mode Elective LUSCS 29 (44.6)   
 Emergency LUSCS not 
in labour 
21 (32.3)   
 Emergency LUSCS in 
labour 
11 (16.9)   
 Classical CS 2 (3.1)   
 Other 2 (3.1)   
MAP No 34 (52.3) 0.17 (0.12-0.24) 1.00 (ref.) 
 Yes 31 (47.7) 173.2 (117.7-245.8) 1000.1 1 (614.7-1627.1) 
Birthweight <2500g 14 (24.1)   
 2500-3999g 40 (68.9)   
 ≥4000g 4 (6.9)   
PH, peripartum hysterectomy; % adjusted for missing data; PH rate per 1000 deliveries; CI, confidence interval; 
cIRR, crude incidence rate ratio; BMI, body mass index; CS, caesarean section; LUSCS, lower uterine segment 
caesarean section; MAP, morbidly adherent placenta; Other delivery mode includes one non-rotational forceps 
and one case of chorioangiocarcinoma; 1 P < .001; 2 P < .01; 3 P < .05.  
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Table 3: Causal factors in cases of peripartum hysterectomy in 2011-2013 by number of previous 
caesarean section deliveries 
Previous CS Placenta 
praevia only 
MAP only Placenta 
praevia & MAP 
Other causes Total 
No 2 0 1 10 13 (22.8%) 
Yes, one 1 2 6 6 15 (26.3%) 
Yes, two or more 7 6 13 3 29 (50.9%) 
Total 10  8 20 19 57 
CS, caesarean section; MAP, morbidly adherent placenta; Other causes were uterine atony (n=9) and 
bleeding from uterine incision (n=5) and cervical laceration, endometritis, pseudoaneurysm, cervical 
cancer and cervical pregnancy each caused one case; Previous history of CS was not reported for 
eight cases. 
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Table 4: Haemostatic surgical procedures in cases of peripartum hysterectomy involving major 
obstetric haemorrhage in 2011-2013 
Procedure n (%) 
None 19 (33.4) 
Intrauterine balloon tamponade 18 (32.7) 
Intra-myometrial carboprost 8 (14.5) 
Manual removal of placenta/retained tissue 7 (12.7) 
Haemostatic brace uterine suturing 6 (10.9) 
Bilateral ligation of uterine arteries 6 (10.9) 
Re-suturing of uterine incision/suturing of lateral extension 5 (9.1) 
Uterine artery embolization (interventional radiology) 3 (5.5) 
Bilateral ligation of iliac arteries 2 (3.6) 
Repair of vaginal/cervical lacerations 2 (3.6) 
Other 5 (9.1) 
Total 56 (100.0) 
Other includes laparotomy, suturing of bladder and haemostatic suture to placental bed 
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